FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606014799> ?p ?o ?g. }

• W2606014799 abstract "Despite advances in our knowledge of effective services for people who use drugs over the last decades globally, coverage remains poor in most countries, while quality is often unknown. This paper aims to discuss the historical development of successful epidemiological indicators and to present a framework for extending them with additional indicators of coverage and quality of harm reduction services, for monitoring and evaluation at international, national or subnational levels. The ultimate aim is to improve these services in order to reduce health and social problems among people who use drugs, such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection, crime and legal problems, overdose (death) and other morbidity and mortality. The framework was developed collaboratively using consensus methods involving nominal group meetings, review of existing quality standards, repeated email commenting rounds and qualitative analysis of opinions/experiences from a broad range of professionals/experts, including members of civil society and organisations representing people who use drugs. Twelve priority candidate indicators are proposed for opioid agonist therapy (OAT), needle and syringe programmes (NSP) and generic cross-cutting aspects of harm reduction (and potentially other drug) services. Under the specific OAT indicators, priority indicators included ‘coverage’, ‘waiting list time’, ‘dosage’ and ‘availability in prisons’. For the specific NSP indicators, the priority indicators included ‘coverage’, ‘number of needles/syringes distributed/collected’, ‘provision of other drug use paraphernalia’ and ‘availability in prisons’. Among the generic or cross-cutting indicators the priority indicators were ‘infectious diseases counselling and care’, ‘take away naloxone’, ‘information on safe use/sex’ and ‘condoms’. We discuss conditions for the successful development of the suggested indicators and constraints (e.g. funding, ideology). We propose conducting a pilot study to test the feasibility and applicability of the proposed indicators before their scaling up and routine implementation, to evaluate their effectiveness in comparing service coverage and quality across countries. The establishment of an improved set of validated and internationally agreed upon best practice indicators for monitoring harm reduction service will provide a structural basis for public health and epidemiological studies and support evidence and human rights-based health policies, services and interventions." @default.
• W2606014799 created "2017-04-28" @default.
• W2606014799 creator A5002446487 @default.
• W2606014799 creator A5002663392 @default.
• W2606014799 creator A5003229688 @default.
• W2606014799 creator A5003819316 @default.
• W2606014799 creator A5006547640 @default.
• W2606014799 creator A5014520220 @default.
• W2606014799 creator A5015717858 @default.
• W2606014799 creator A5020021150 @default.
• W2606014799 creator A5025141447 @default.
• W2606014799 creator A5026003500 @default.
• W2606014799 creator A5029759341 @default.
• W2606014799 creator A5036570109 @default.
• W2606014799 creator A5039516267 @default.
• W2606014799 creator A5041340102 @default.
• W2606014799 creator A5044857284 @default.
• W2606014799 creator A5051618789 @default.
• W2606014799 creator A5054263848 @default.
• W2606014799 creator A5054371256 @default.
• W2606014799 creator A5057551601 @default.
• W2606014799 creator A5061301793 @default.
• W2606014799 creator A5066320010 @default.
• W2606014799 creator A5070146233 @default.
• W2606014799 creator A5071867075 @default.
• W2606014799 creator A5073629679 @default.
• W2606014799 creator A5077446896 @default.
• W2606014799 creator A5077727821 @default.
• W2606014799 creator A5081914176 @default.
• W2606014799 creator A5085208411 @default.
• W2606014799 creator A5088996103 @default.
• W2606014799 creator A5091620489 @default.
• W2606014799 creator A5091898734 @default.
• W2606014799 date "2017-04-22" @default.
• W2606014799 modified "2023-10-11" @default.
• W2606014799 title "Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study" @default.
• W2606014799 cites W1267788392 @default.
• W2606014799 cites W1469340768 @default.
• W2606014799 cites W1498386965 @default.
• W2606014799 cites W1508535923 @default.
• W2606014799 cites W1573120869 @default.
• W2606014799 cites W1891114921 @default.
• W2606014799 cites W1925677430 @default.
• W2606014799 cites W1938600615 @default.
• W2606014799 cites W1949412152 @default.
• W2606014799 cites W1964717538 @default.
• W2606014799 cites W1967228793 @default.
• W2606014799 cites W1969077049 @default.
• W2606014799 cites W1974123594 @default.
• W2606014799 cites W1975806001 @default.
• W2606014799 cites W1980535262 @default.
• W2606014799 cites W1981264647 @default.
• W2606014799 cites W1982205882 @default.
• W2606014799 cites W1982618956 @default.
• W2606014799 cites W1984200522 @default.
• W2606014799 cites W1984761129 @default.
• W2606014799 cites W1989724684 @default.
• W2606014799 cites W1990291753 @default.
• W2606014799 cites W1995416328 @default.
• W2606014799 cites W1996747770 @default.
• W2606014799 cites W1997761706 @default.
• W2606014799 cites W2001156227 @default.
• W2606014799 cites W2004368291 @default.
• W2606014799 cites W2004969769 @default.
• W2606014799 cites W2011437704 @default.
• W2606014799 cites W2017959122 @default.
• W2606014799 cites W2020073425 @default.
• W2606014799 cites W2022432897 @default.
• W2606014799 cites W2026516196 @default.
• W2606014799 cites W2029152225 @default.
• W2606014799 cites W2030945355 @default.
• W2606014799 cites W2031561193 @default.
• W2606014799 cites W2031965361 @default.
• W2606014799 cites W2033716416 @default.
• W2606014799 cites W2034638355 @default.
• W2606014799 cites W2035304784 @default.
• W2606014799 cites W2036809861 @default.
• W2606014799 cites W2038763023 @default.
• W2606014799 cites W2038871251 @default.
• W2606014799 cites W2041648758 @default.
• W2606014799 cites W2045031224 @default.
• W2606014799 cites W2048176377 @default.
• W2606014799 cites W2048697063 @default.
• W2606014799 cites W2052614821 @default.
• W2606014799 cites W2053863509 @default.
• W2606014799 cites W2058976307 @default.
• W2606014799 cites W2062285874 @default.
• W2606014799 cites W2062334554 @default.
• W2606014799 cites W2063054932 @default.
• W2606014799 cites W2068269273 @default.
• W2606014799 cites W2068433963 @default.
• W2606014799 cites W2071105551 @default.
• W2606014799 cites W2083705543 @default.
• W2606014799 cites W2083759548 @default.
• W2606014799 cites W2085185655 @default.
• W2606014799 cites W2085206387 @default.
• W2606014799 cites W2087605942 @default.
• W2606014799 cites W2087944593 @default.
• W2606014799 cites W2097603150 @default.
• W2606014799 cites W2098465493 @default.

• next